INTRODUCTION
Patients with cirrhosis may create intense inconveniences, for example, ascites, hepatic encephalopathy, gastrointestinal bleeding, and bacterial infection necessitate hospitalization [1]. On admission, a portion of these patients will have insignificant decompensated cirrhosis, though others will show decompensated cirrhosis related with recently created liver or potentially additional hepatic organ disappointment [2] .
Patients with cirrhosis and intense organ disappointment are at high hazard for momentary passing. It has turned out to be standard to allude to these people as patients with intense acuteon-chronic liver failure (ACLF). ACLF scenes are in charge of an enormous extent of the social insurance costs owing to intense decompensation of cirrhosis.
Subsequently, the advancement of ACLF is a significant result in clinical preliminaries, and its avoidance is a key segment of cirrhosis [3, 4] .
It is suggested that the Sequential Organ Failure Assessment (SOFA) score be used to diagnose failure of organs in patients with cirrhosis referred to hospital [5] . Like the original score, the Chronic liver failure (CLIF)-SOFA score assessed six organ (circulation, kidneys, liver, lungs, brain and coagulation); function tests of the kidney is deteriorated in ACLF patients [6] .
There is some agents for AKI detection, including: kidney injury molecule 1 (KIM-1), interleukin-18 (IL-18) and NGAL (uNGAL) and blood neutrophil gelatinase lipocalin (sNGAL) and cystatin C [7]. (KIM-1) has definite properties so it is a perfect reagent of harmness of the kidney [8].
The Aim of This Work
This work aims to investigate non-invasive reagents for speedy detection, prognostic indicators and their association with adverse events, mainly mortality for AKI in ACLF patients.
PATIENTS AND METHODS
Our study was case control study. Table 1 exhibits a differentiation uniting the examined gatherings as regards to the data related to stricture of population. It exhibits that there is no remarkable differentiation between the two examined gatherings as regards to sex and age. Table 2 exhibits a differentiation between the examined groups as regards to routine laboratory parameters, It exhibits that there is remarkable differentiation between the two examined groups as regards to ALT and AST, while no remarkable differentiation as regards to creatinine, INR, platelets and total bilirubin levels. Also no remarkable differentiation between the two examined groups as regards to albumin, total protein and WBCs. Table 3 exhibits that there is remarkable differentiation between the two examined groups as regards to ascites and Glasgow coma scale. But there is no remarkable differentiation between the examined groups as regards to GI bleeding, encephalopathy and jaundice. Table 4 exhibits there is remarkable differentiation between the examined groups as regards to kidney affection by ultrasonography but no remarkable differentiation between the examined groups as regards to liver enlargement, and splenic enlargement. Table 5 exhibits that there is high remarkable differentiation between the examined groups as regards to Child Pugh classification. Table 6 exhibits that there is high remarkable differentiation between the examined groups as regards to Clif sofa score. Table 7 exhibits that there is high remarkable differentiation between the two examined groups as regards to KIM-1.
RESULTS

ROC curve
On blotting ROC curve to test diagnostic performance of KIM-1 in detecting the AKI. It shows that at cut off value of ≥0.5 KIM-1 can predict the presence of AKI with sensitivity of 85.7%, specificity 88.1%, positive predictive value 87.8%, negative predictive value 86%, accuracy 86.9% and AUC= 0.867 p<0.001 (Table 8 ). Table 9 exhibits that there is high rejection remarkable interdependence between KIM-1 and Glasgow coma scale. The lower the level of KIM-1 the higher the Glasgow coma scale. Also there is a positive significant correlation between KIM -1 and kidney affection by ultrasonography. Table 11 exhibits that KIM -1 is remarkable predictor for acute kidney injury as it is 11-12 times alike to be higher in AKI patients. 
DISCUSSION
Renal affection in cirrhotic patients is a major problem and occurs in one of each five hepatic patients. It might be in the form of long standing kidney disease or worse in the form of sudden kidney injury. Unfortunately AKI is accompanied by big death rate ; that necessitates development of early noninvasive and simple marker for speedy determination of AKI. Many markers had been discovered recently like Neutrophil gelatinase-related lipocalin (NGAL), IL-18, Liver sort unsaturated fat restricting protein (L-FABP) and Kidney damage particle 1 (KIM-1)
Our experiment included 84 patients, allocated into two groups each including 42 patients. First group included non ACLF patients. The second group incorporate patients who met the criteria of ACLF as indicated by CLIF-SOFA scoring framework. Patients were entered to Zagazig University and Al Ahrar Hospitals in the range of 2015 and 2018. The point of this investigation was to test the job of one of the new biomarkers, KIM-1, for early discovery, common course and prognostic contrasts of AKI between patients with and without ACLF.
KIM-1 is a trans-layer protein with clear favorable circumstances as another marker for the early conclusion of AKI. In ordinary kidney tissue, it is for every targets and justifications not communicated yet it is communicated at moderate to abnormal states in the endothelial cells of the proximal tangled tubules during the beginning times of renal ischemic or nephrotoxic damage [10] .
Heterogeneity of definitions ACLF is a disorder described by intense and serious hepatic variations from the norm coming about because of various sorts of abuse, in patients with hidden endless liver malady or cirrhosis at the same time, rather than decompensated cirrhosis, has a high transient mortality, copying the forecast of extreme liver disappointment. By and by, the key terms of the definition 'intense', 'interminable liver' and 'disappointment' have a few varieties and an ongoing methodical audit announced up to 13 meanings of ACLF [11] . Given this heterogeneity and the significance of recognizing ACLF patients for a more assisted triage and stir up, four noteworthy social orders/associations have given working definitions that, despite the fact that not steady, lay the preparation for subsequent experimentation [12] . The Current examination is the first to research contrasts in AKI among ACLF and cirrhotic patients in our territory by assessing of the degrees of novel rounded harm biomarkers KIM-1 in various gatherings.
The present study showed that KIM-1 was significantly higher in ACLF (7.35 In the current study there is noteworthy distinction between the two contemplated groups as respect ALT and AST levels, while no critical contrast were found in our work as respect of level of serum albumin, INR, creatinine, protein, bilirubin level and CBC .This finding was steady with Shi Y, et al, who considered group of patients with HBV -ACLF [17].
Our outcomes propose that AKI happening in patients with or without ACLF ought to be overseen in various ways. Huge scale multifocus studies are required to approve these discoveries, and the distinctions in AKI between patients with or without ACLF brought about by different reasons rather than HCV still should be additionally studied.
CONCLUSION
ACLF is a serious condition that happens on the foundation of interminable liver brokenness and results in the advancement of organ disappointment and is related with extremely high mortality especially if accompanied by AKI. KIM-1 is a dependable agent for detection of AKI with ACLF.
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